STOCKWATCH
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
MergerMay 4, 2026, 09:07 AM

Masimo Shareholders Approve Danaher Merger Agreement

AI Summary

Masimo Corporation stockholders approved the Agreement and Plan of Merger with Danaher Corporation at a special meeting held on May 1, 2026. Under the terms, Masimo will become a wholly owned subsidiary of Danaher, with shareholders receiving $180.00 in cash per share. Stockholders also approved, on an advisory basis, the merger-related compensation for named executive officers. The merger is subject to regulatory approvals and is expected to close in 2026.

Key Highlights

  • Masimo stockholders approved the merger agreement with Danaher Corporation.
  • The merger agreement proposal received 36,981,681 votes in favor.
  • Stockholders approved the non-binding advisory compensation proposal with 34,561,175 votes in favor.
  • Each share of common stock will be converted into the right to receive $180.00 in cash.
  • A total of 52,362,808 shares of common stock were outstanding on the record date.
  • The merger is expected to close in 2026, subject to customary closing conditions and regulatory approvals.
MASI
Biotechnology: Electromedical & Electrotherapeutic Apparatus
MASIMO CORP

Price Impact